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954 Robotic pulmonary lobectomy—The future and probably should remain so
Scott J. Swanson, MD, Boston, MassA
CDExpert Review 955 The Society of Thoracic Surgeons National Adult Cardiac Database: A
continuing commitment to excellence
David M. Shahian, MD, Fred Edwards, MD, Fred L. Grover, MD, Jeffrey P. Jacobs, MD,
Cameron D. Wright, MD, Richard L. Prager, MD, Jeffrey B. Rich, MD, Michael J. Mack, MD,
and Douglas J. Mathisen, MD, Boston, Mass; Jacksonville and St. Petersburg, Fla; Denver,
Colo; Ann Arbor, Mich; Norfolk, Va; and Dallas, TexDCommentaryCH960 Data entry and data accuracy
Hartzell V. Schaff, MD, Morgan L. Brown, MD, PhD, and Judy R. Lenoch, Rochester, Minn, and
Edmonton, Alberta, CanadaGeneral Thoracic
Surgery (GTS)PM962 Long-term results of the Heller–Dor operation with intraoperative manometry
for the treatment of esophageal achalasia
Sandro Mattioli, MD, Alberto Ruffato, MD, PhD, Marialuisa Lugaresi, MD, PhD, Vladimiro Pilotti,
MD, Beatrice Aramini, MD, and Frank D’Ovidio, MD, PhD, Cotignola, Italy, and New York, NY
Most centers use the Heller–Dor technique for achalasia, but the results are inconsistent. We
analyzed the technical details of myotomy and fundoplication in relation to the long-term outcome of
the procedure. Intraoperative manometry was very useful for learning how to perform a myotomy
and how to calibrate the delicate balance between esophagogastric transit and gastroesophageal
reflux.
970 General thoracic surgery is safe in patients taking clopidogrel (Plavix)
Robert James Cerfolio, MD, FACS, FCCP, Douglas J. Minnich, MD, and Ayesha S. Bryant, MSPH,
MD, Birmingham, AlaET
/B
SPatients who have had a coronary artery stent placed and are receiving clopidorgrel can safely
undergo most thoracic operations, except redo thoracotomy, with little risk of bleeding. This new
finding simplifies the preoperative management of these patients with anesthesia and cardiology and
may reduce their risk of perioperative myocardial infarction.(continued on page 12A)
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S977 Should asymptomatic enlarged thymus glands be resected?
Smit Singla, MD, MRCS (Edinburgh), MSc, Leslie A. Litzky, MD, Larry R. Kaiser, MD, FACS, and
Joseph B. Shrager, MD, Philadelphia, Pa, Houston, Tex, and Stanford, Calif
Not infrequently, an ‘‘enlarged thymus’’ is incidentally identified on imaging. On the basis of our
retrospective review, we propose that asymptomatic patients (without myasthenia gravis) who have
a diffusely enlarged thymus gland can be followed up expectantly without thymectomy, because they
have negligible incidence of significant thymic disease.984 Analysis of clamping versus cutting of T3 sympathetic nerve for severe palmar
hyperhidrosis
Ted K. Yanagihara, MPhil, Ali Ibrahimiye, MD, Catherine Harris, MD, Joy Hirsch, PhD,
and Lyall A. Gorenstein, MD, New York, NY, and San Francisco, Calif
Debate exists over the use of cutting versus clamping of the sympathetic nerve for the treatment of
primary palmar hyperhidrosis. We have provided evidence that clamping might be a preferable
technique, because of its potential reversibility and similar outcomes to those of cutting.990 Branched vascular network architecture: A new approach to lung assist device
technology
David M. Hoganson, MD, Jennifer L. Anderson, MD, Eli F. Weinberg, PhD, Eric J. Swart, BS, Brian
K. Orrick, BS, Jeffrey T. Borenstein, PhD, and Joseph P. Vacanti, MD, Boston and Cambridge, Mass
In contrast with hollow fiber oxygenators, a new architecture for a lung assist device has been
developed centered on a branched vascular network for blood flow similar to native pulmonary
circulation. In this device, efficient gas exchange occurs across a thin silicone membrane.996 Tumor angiogenesis in predicting the survival of patients with stage I lung
cancer
Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin Melek, MD,
Nur Buyukpinarbasili, MD, Neslihan Fener, MD, and Seyyit Ibrahim Dincer, MD, Istanbul, Turkey
The effects of angiogenesis on survival were assessed by measuring the tumor microvessel density
(MVD) and vascular endothelial growth factor (VEGF) expression in patients with resected stage I
non–small cell lung carcinoma. MVD, but not VEGF level, was found as a predictor of prognosis in
these patients.Acquired Cardiovascular
Disease (ACD)1001 Superior nationwide outcomes of endovascular versus open repair for isolated
descending thoracic aortic aneurysm in 11,669 patients
Raja R. Gopaldas, MD, Joseph Huh, MD, Tam K. Dao, PhD, Scott A. LeMaire, MD,
Danny Chu, MD, Faisal G. Bakaeen, MD, and Joseph S. Coselli, MD, Houston, Tex
Using nationwide data collected during a 2-year period, we compared the in-hospital outcomes of
thoracic endovascular aneurysm repair and open aortic repair for descending thoracic aortic
aneurysms. Compared with open aortic repair, thoracic endovascular aneurysm repair was associated
with a shorter hospital length of stay and fewer complications.(continued on page 14A)
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S1011 Cardiac catheterization within 24 hours of valve surgery is significantly
associated with acute renal failure
Sara A. Hennessy, MD, Damien J. LaPar, MD, George J. Stukenborg, PhD, Matthew L. Stone, MD,
Ryan A. Mlynarek, BS, John A. Kern, MD, Gorav Ailawadi, MD, and Irving L. Kron, MD,
Charlottesville, Va
Acute renal failure after valve surgery can be a devastating complication. The risk of acute renal
failure was 5 times higher for patients undergoing cardiac catheterization within 24 hours of surgery.
Current practices should be adjusted to ensure that more than 24 hours have passed from the time of
catheterization to surgery in elective settings.
1018 Perioperative statin therapy reduces mortality in normolipidemic patients
undergoing cardiac surgery
Muthiah Vaduganathan, BA, Neil J. Stone, MD, Richard Lee, MD, MBA, Edwin C. McGee, Jr, MD,S. Chris Malaisrie, MD, Robert A. Silverberg, MD, and Patrick M. McCarthy, MD, Chicago, Ill
We evaluated 3056 consecutive cardiac surgery patients from 2004 to 2009 in 4 groups: (1) statin-
untreated normolipidemic patients (n = 1052); (2) statin-treated normolipidemic patients (n = 206);
(3) statin-untreated hyperlipidemic patients (n = 638); and (4) statin-treated hyperlipidemic patients
(n = 1160). The all-cause mortality rate at a mean of 2.2 years was 9.6% (101/1052), 3.9% (8/206),
17.2% (110/638), and 6.5% (75/1160) for the statin untreated normolipidemic, statin-treated
normolipidemic, statin-untreated hyperlipidemic, and statin-treated hyperlipidemic groups,
respectively. The use of statins in normolipidemic cardiac surgery patients independently reduced
mortality (adjusted hazard ratio, 0.34; 95% confidence interval, 0.16–0.71; P = .004).
1028 Identifying patients at particular risk of injury during repeat sternotomy:
Analysis of 2555 cardiac reoperations
Chan B. Park, MD, Rakesh M. Suri, MD, Harold M. Burkhart, MD, Kevin L. Greason, MD, Joseph A.
Dearani, MD, Hartzell V. Schaff, MD, and Thoralf M. Sundt III, MD, Rochester, Minn, and Seoul, Korea
Patients who have previously undergone radiotherapy, have undergone multiple previous
sternotomies, or have patent internal thoracic artery grafts are at increased risk of injury during repeat
median sternotomy and warrant particular attention to protective strategies. Although only one third
of injuries occur during sternal division, they have been more strongly associated with mortality.
1036 Prophylactic ventral cardiac denervation: Does it reduce incidence of atrial
fibrillation after coronary artery bypass grafting?
Abbas Salehi Omran, MD, Abbasali Karimi, MD, Hossein Ahmadi, MD, Parin Yazdanifard, MD,
Mahmood Sheikh Fahtollahi, PhD, and Mokhtar Tazik, MD, Tehran, Iran
This study suggests that ventral cardiac denervation during coronary artery bypass grafting does not
have a prophylactic effect on atrial fibrillation after coronary artery bypass grafting.
1040 Off-pump bilateral internal thoracic artery grafting in patients with left main
disease
Toshihiro Fukui, MD, PhD, Minoru Tabata, MD, MPH, Susumu Manabe, MD, PhD, Tomoki
Shimokawa, MD, PhD, Jun Shimizu, MD, PhD, Satoshi Morita, MD, PhD, and Shuichiro Takanashi,
MD, Tokyo and Yokohama, Japan
We compared the clinical and angiographic outcomes of off-pump bilateral internal thoracic artery
grafting in patients with and without left main disease. Clinical outcomes and patency rates of left and
right internal thoracic artery grafts did not differ significantly in patients with or without left main disease.(continued on page 16A)
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S1046 Prevalence and clinical significance of acquired left coronary artery fistulas
after surgical myectomy in patients with hypertrophic cardiomyopathy
Aurelio Sgalambro, MD, Iacopo Olivotto, MD, Alessandra Rossi, MD, Stefano Nistri, MD,
Katia Baldini, MD, Massimo Baldi, MD, Pierluigi Stefano, MD, David Antoniucci, MD,
Francesca Garbini, MD, Franco Cecchi, MD, and Magdi H. Yacoub, MD, FRS, Florence, Italy,
and London, United Kingdom
We prospectively defined the prevalence and clinical significance of iatrogenic left coronary artery
fistulas (LCAFs) in 40 patients with hypertrophic cardiomyopathy undergoing septal myectomy.
LCAFs were common in the early postoperative period (9 [23%] patients) but were rarely persistent
(n 5 2). However, 1 patient required percutaneous closure of a large first septal branch fistula
associated with coronary artery steal.1053 Influence of the On-X mechanical prosthesis on intermediate-term major
thromboembolism and hemorrhage: A prospective multicenter study
Vincent Chan, MD, W. R. Eric Jamieson, MD, B-Khanh Lam, MD, MSc, Marc Ruel, MD, MPH,
Hilton Ling, MD, Guy Fradet, MD, and Thierry G. Mesana, MD, PhD, Ottawa, Ontario, and
Vancouver, British Columbia, Canada
This prospective multicenter study was conducted to evaluate major thromboembolism and
hemorrhage after mechanical valve replacement with the On-X prosthesis. The On-X prosthesis
offers favorable intermediate-term outcomes when implanted in either the aortic or mitral
position.Congenital Heart
Disease (CHD)1059 Persistent risk of subsequent procedures and mortality in patients after
interrupted aortic arch repair: A Congenital Heart Surgeons’ Society study
Anusha Jegatheeswaran, Hon.BSc, MD, Brian W. McCrindle, MD, MPH, Eugene H. Blackstone,
MD, Marshall L. Jacobs, MD, Gary K. Lofland, MD, Earl H. Austin III, MD, Thomas Yeh, MD, PhD,
Victor Morell, MD, Jeffrey P. Jacobs, MD, Richard A. Jonas, MD, Sally Cai, MSc, Jeevanantham
Rajeswaran, MSc, Marco Ricci, MD, William G. Williams, MD, Christopher A. Caldarone, MD, and
William M. DeCampli, MD, PhD, Toronto, Ontario, Canada; Cleveland, Ohio; Kansas, Mo;
Louisville, Ky; New Orleans, La; Pittsburgh, Pa; Saint Petersburg, Miami, and Orlando, Fla; and
Washington, DC
We reviewed the data from 447 patients with interrupted aortic arch enrolled from 1987 to 1997.
After the initial repair, patients often undergo subsequent procedures with a persistent risk of
additional intervention and mortality, which depends on morphology, surgical method, and the
nature and timing of previous procedures. An interrupted aortic arch should be considered a chronic
disorder.1076 In situ pericardial extracardiac lateral tunnel Fontan operation: Fifteen-year
experience
Nahidh W. Hasaniya, MD, PhD, Anees J. Razzouk, MD, Neda F. Mulla, MD, Ranae L. Larsen, MD,
and Leonard L. Bailey, MD, Loma Linda, Calif
In situ pericardial extracardiac lateral tunnel Fontan operation is reviewed in 160 patients over
15 years’ follow-up. The tunnel is a relatively simple, durable, and safe operation. Long-term follow-
up confirms low morbidity and mortality. Fenestration is unnecessary in most patients.
Echocardiography showed that this viable tunnel adapts to physiologic flow demands.(continued on page 18A)
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S1084 Precise evaluation of bilateral pulmonary artery banding for initial palliation in
high-risk hypoplastic left heart syndrome
Kazuo Kitahori, MD, PhD, Arata Murakami, MD, PhD, Tetsuhiro Takaoka, MD,
Shinichi Takamoto, MD, PhD, and Minoru Ono, MD, PhD, Bunkyo-Ku, Tokyo, Japan
Bilateral pulmonary artery banding is effective in patients with high-risk hypoplastic left heart
syndrome. The Norwood operation as a second-stage procedure can be performed more safely than in
the neonatal period. We found the suitable band sizes to be the patient’s body weight plus 7 mm for
the left pulmonary artery and the body weight plus 7.5 mm for the right pulmonary artery.
1092 Determinants of outcome after surgical treatment of pulmonary atresia with
ventricular septal defect and major aortopulmonary collateral arteries
Adriano Carotti, MD, Sonia B. Albanese, MD, Sergio Filippelli, MD, Lucilla Rava`, PhD, Paolo
Guccione, MD, Giacomo Pongiglione, MD, and Roberto M. Di Donato, MD, Rome, Italy
The results of unifocalization in patients with pulmonary atresia, ventricular septal defect, and major
aortopulmonary collateral arteries were satisfactory and durable. The outcomes were negatively
affected by neonatal age, low body weight, and chromosome 22q11 deletion and positively affected
by simultaneous or staged ventricular septal defect closure, which increased the chance of a positive
outcome.
1104 Repair of major congenital cardiac defects in low-birth-weight infants: Is delay
warranted?
Charles W. Shepard, MD, Lazaros K. Kochilas, MD, Ronald M. Rosengart, MD,Ann M. Brearley, PhD, MS, Roosevelt Bryant III, MD, James H. Moller, MD, and
James D. St. Louis, MD, Minneapolis, Minn, and Los Angeles, Calif
For infants undergoing a major cardiac procedure, the survival of those weighing less than 1.5 kg was
comparable to that of infants who underwent the procedure weighing 1.5 to 2.5 kg. Therefore,
operative delay secondary to patient weight might be unwarranted.
1110 Leaflet suspension to the contralateral annulus to address restriction or
tethering-induced mitral and tricuspid regurgitation in children: results of
a case-control study
Patrick O. Myers, MD, Jan T. Christenson, MD, Mustafa Cikirikcioglu, MD, PhD, Ce´cile Tissot, MD,
Yacine Aggoun, MD, and Afksendiyos Kalangos, MD, PhD, Geneva, Switzerland, and Boston, Mass
Acceptable coaptation cannot always be obtained using standard repair techniques for type III mitral
or tricuspid regurgitation. A new leaflet suspension technique improved coaptation and avoided or
delayed valve replacement, with acceptable transvalvular gradients that did not increase with growth
and were not significantly different in the matched control group.Perioperative
Management (PM)1117 Thromboelastometrically guided transfusion protocol during aortic surgery
with circulatory arrest: A prospective, randomized trial
Evaldas Girdauskas, MD, Jo¨rg Kempfert, MD, Thomas Kuntze, MD, Michael A. Borger, MD, PhD,
Jo¨rg Enders, MD, Jens Fassl, MD, Volkmar Falk, MD, PhD, and Friedrich-Wilhelm Mohr, MD,
PhD, Leipzig, Germany
Aortic surgical patients undergoing hypothermic circulatory arrest with a thromboelastometrically
guided transfusion algorithm had a 44% reduction in the cumulative use of allogeneic blood units
relative to a control group (P = .02).(continued on page 20A)
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S1125 Infections occurring during extracorporeal membrane oxygenation use in adult
patients
Hsin-Yun Sun, MD, Wen-Je Ko, MD, Pi-Ru Tsai, RN, Chun-Chuan Sun, RN, Yin-Yin Chang, RN,
Ching-Wen Lee, MS, and Yee-Chun Chen, MD, PhD, Taipei, Taiwan, and Pittsburgh, Pa
Bloodstream infection is the most common infection occurring during extracorporeal membrane
oxygenation (ECMO) use in adults. Independent risk factors for these infections include duration of
ECMO use, mechanical complications, autoimmune disease, and receipt of venovenous mode.
Infections during ECMO use in adults have no significant impact on in-hospital mortality.
1133 Major complications during negative pressure wound therapy in
poststernotomy mediastinitis after cardiac surgery
Rainer Petzina, MD, PhD, Malin Malmsjo¨, MD, PhD, Christof Stamm, MD, PhD,
and Roland Hetzer, MD, PhD, Berlin, Germany, and Lund, Sweden
Negative pressure wound therapy is the first-line treatment modality for poststernotomy mediastinitis.
The aim of this study was to analyze major complications (bleeding) and possible preventive methods
during negative pressure wound therapy.Evolving Technology/
Basic Science (ET/BS)1137 Coil spring fiducial markers placed safely using navigation bronchoscopy in
inoperable patients allows accurate delivery of CyberKnife stereotactic
radiosurgery
Carsten Schroeder, MD, PhD, Rana Hejal, MD, and Philip A. Linden, MD, Cleveland, Ohio
Electromagnetic navigation bronchoscopy can be used to deploy fiducial markers for CyberKnife
radiosurgery of lung tumors safely and accurately with fewer complications than those using
computed tomography-guided placement. Coil-spring fiducial markers rarely dislocate and,
therefore, the repeat procedure rate and/or CyberKnife tracking errors were reduced.
1143 Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition
on ischemic myocardium
Michael P. Robich, MD, MSPH, Louis M. Chu, MD, Jun Feng, MD, PhD, Thomas A. Burgess, MA,
Roger J. Laham, MD, Cesario Bianchi, MD, PhD, and Frank W. Sellke, MD, Providence, RI, and
Boston, Mass
Selective cyclooxygenase-2 inhibitors are purported to increase adverse cardiovascular events. In
this swine study, selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition
diminished capillary density, endothelial cell turnover, and circulating and tissue levels of
prostacyclin and proangiogenic factors; however, they did not decrease collateral-dependent flow to
the myocardium.
1153 Diazoxide maintenance of myocyte volume and contractility during stress:
Evidence for a non-sarcolemmal KATP channel location
Angela D. Sellitto, MS, Sara K. Maffit, BS, Ashraf S. Al-Dadah, MD, Haixia Zhang, PhD,
Richard B. Schuessler, PhD, Colin G. Nichols, PhD, and Jennifer S. Lawton, MD, St Louis, Mo
To block cardioplegic myocyte swelling, diazoxide requires the KATP channel subunit SUR1, but
does not involve an increase in sarcolemmal KATP channel current, implicating a non-sarcolemmal
KATP channel site of action.(continued on page 22A)
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S1160 Myocardial infarction in rats causes partial impairment in insulin response
associated with reduced fatty acid oxidation and mitochondrial gene expression
Paulo A. Amorim, MD, T. Dung Nguyen, BS, Yasushige Shingu, MD, Michael Schwarzer, PhD,
Friedrich W. Mohr, MD, PhD, Andrea Schrepper, MS, and Torsten Doenst, MD, PhD, Leipzig,
Germany
We investigated the insulin response and mitochondrial function after rat left coronary artery ligation.
Insulin’s effect was impaired for substrate oxidation but normal for glucose uptake. The gene
expression for fatty acid oxidation and mitochondrial biogenesis was reduced. Myocardial infarction
is associated with mitochondrial dysfunction and partial insulin resistance at the level of substrate
oxidation.1168 Preliminary results of anatomic lung resection using energy-based tissue and
vessel coagulative fusion technology
Matthew J. Schuchert, MD, Ghulam Abbas, MD, Brian L. Pettiford, MD, James D. Luketich, MD,
and Rodney J. Landreneau, MD, Pittsburgh, Pa
Bipolar vessel fusion technology was applied in 211 anatomic lung resections. Two partial venous
dehiscences (0.9%) and no arterial dehiscences were observed after division of 476 arteries and 229
veins, with no delayed bleeding. Energy-based tissue fusion devices represent a reasonable
alternative to mechanical staplers during anatomic lung resection.1174 Spliced stromal cell-derived factor-1a analog stimulates endothelial progenitor
cell migration and improves cardiac function in a dose-dependent manner after
myocardial infarction
William Hiesinger, MD, John R. Frederick, MD, Pavan Atluri, MD, Ryan C. McCormick, BS,
Nicole Marotta, BS, Jeffrey R. Muenzer, BS, and Y. Joseph Woo, MD, Philadelphia, Pa
A spliced peptide analog of stromal cell-derived factor-1a containing both the N- and C- termini of
the native protein induced endothelial progenitor cell migration and improved ventricular function
after acute myocardial infarction. It thus provides a novel foundation for the clinical translation of
cytokine-based neovasculogenic therapy.1181 Improved left ventricular unloading and circulatory support with synchronized
pulsatile left ventricular assistance compared with continuous-flow left
ventricular assistance in an acute porcine left ventricular failure model
George V. Letsou, MD, Thomas D. Pate, MS, Jeffrey R. Gohean, MS, Mark Kurusz, BA, CCP,
Raul G. Longoria, PhD, Larry Kaiser, MD, and Richard W. Smalling, MD, PhD, Houston and
Austin, Tex
Left ventricular (LV) unloading and circulatory support with pulsatile LV assist synchronized to the
cardiac cycle was compared with continuous-flow LV assist at the same flow rate. During LV failure,
the pulsatile LV assist device resulted in higher total cardiac output, higher mean aortic pressure, and
lower left atrial pressure compared with the continuous-flow LV assist device.Cardiothoracic Imaging 1189 Pericardial, pleural, and diaphragmatic endometriosis
Marcello Ceccaroni, MD, PhD, Roberto Clarizia, MD, and Angelo Placci, MD, Verona, Naples,
and Ravenna, Italy(continued on page 24A)
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SBrief Technique Reports24A The Journal of Thoracic an1191 Valve-sparing procedure and Lecompte maneuver in patients with late aortic
regurgitation and aortic aneurysm after the arterial switch operation
Yih-Sharng Chen, MD, PhD, Ing-Sh Chiu, MD, PhD, Shu-Chien Huang, MD,
and Shyh-Jye Chen, MD, Taipei, Taiwan
1193 Translocation of a single coronary artery from the nonfacing sinus in the
arterial switch operation: Long-term patency of the interposition graft
Igor E. Konstantinov, MD, PhD, Tyson A. Fricke, BMedSci, Yves d’Udekem, MD, PhD,
and Dorothy J. Radford, MBBS, MD, Melbourne and Brisbane, Australia
1195 Radiolucent retractor for angiographic analysis during hybrid congenital
cardiac procedures
Gareth J. Morgan, MB, BaO, BCh, MRCPCH, MPhil, Karen Clarke, RN, Christopher Caldarone,
MD, and Lee N. Benson, MD, FRCPC, Toronto, Ontario, Canada
1196 Palliative role of percutaneous radiofrequency ablation for severe hemoptysis in
an elderly patient with inoperable lung cancer
Alessandro Baisi, MD, Federico Raveglia, MD, Matilde De Simone, MD, PhD,
and Ugo Cioffi, MD, PhD, Milan, Italy
1198 Reconstruction of a resected subclavian vein by transposition of the ipsilateral
internal jugular vein
Michel Gonzalez, MD, Se´bastien De´glise, MD, Hans-Beat Ris, MD, and Jean-Marc Corpataux, MD,
Lausanne, SwitzerlandOnline Only:
Brief Clinical Reportse67 Thyroid storm after coronary artery bypass grafting
Lawrence T. Bish, PhD, Joseph E. Bavaria, MD, and John Augoustides, MD, FASE, FAHA,
Philadelphia, Pa
e69 Salvage surgery for advanced non–small cell lung cancer after response to
gefitinib
Tomoyuki Hishida, MD, Kanji Nagai, MD, Tetsuya Mitsudomi, MD, Kohei Yokoi, MD, Haruhiko
Kondo, MD, Hirohisa Horinouchi, MD, Hirohiko Akiyama, MD, Takeshi Nagayasu, MD, and
Masahiro Tsuboi, MD, and The Japan Clinical Oncology Group, Chiba, Aichi, Shizuoka, Tokyo,
Saitama, Nagasaki, and Kanagawa, Japan
e71 Aortic dissection and rupture in adolescents after tetralogy of Fallot repair
Igor E. Konstantinov, MD, PhD, Tyson A. Fricke, BMedSci, Yves d’Udekem, MD, PhD, and
Terry Robertson, MBBS, FRACP, Melbourne and Adelaide, Australia
e73 Simple preoperative management for cold agglutinins before cardiac surgery
Shinji Kanemitsu, MD, Koji Onoda, MD, Kiyohito Yamamoto, MD, and Hideto Shimpo, MD,
Tsu City, Japan
e75 Concomitant mitral valve replacement and re-re-repair of severe pectus
deformity correction in a patient with Marfan syndrome
Christoph Haller, MD, Koppany Sarai, MD, Matthias Siepe, MD, and Friedhelm Beyersdorf, MD,
Freiburg, Germany
e76 A rare case of vascular ring: Retroesophageal artery between the right
brachiocephalic artery and the left descending aorta
Yoshio Ootaki, MD, PhD, Mohamed Sulaiman, MD, and Ross M. Ungerleider, MD, Cleveland, Ohio(continued on page 26A)
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Se78 Disseminated primary coccidioidomycosis of the chest wall
Kimberly Evans, MD, Royce F. Calhoun, MD, Hugh Black, MD, and David T. Cooke, MD,
Sacramento, Calif
e80 Williams–Beuren syndrome: An unusual cause of neonatal and infantile
coarctation
Issam Kammache, MD, Philippe Acar, MD, PhD, Bernard Kreitmann, MD, PhD,
and Alain Fraisse, MD, PhD, Marseille and Toulouse, France
e81 Aortic dissection caused by aortitis associated with hepatitis C virus–related
cryoglobulinemia
Naoto Fukunaga, MD, Hiroshi Fujiwara, MD, Michihiro Nasu, MD, and Yukikatsu Okada, MD,
Kobe, Japan
e83 Mitroflow pericardial aortic bioprosthesis in patients younger than 60 years
Charles A. Yankah, MD, PhD, Berlin, GermanyLetters to the Editor 1200 Relation between hemodynamic behavior and occurrence of early stenotic
failure of bioprostheses
Bart Meuris, MD, PhD, and Willem Flameng, MD, PhD, Leuven, Belgium
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W. R. Eric Jamieson, MD, and Guy J. Fradet, MD, Vancouver, British Columbia, Canada
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Justin Nowell, MRCS, and Marjan Jahangiri, FRCS, London, United Kingdom
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Andrew W. ElBardissi, MD, MPH, and Lawrence H. Cohn, MD, Boston, Mass
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